<?xml version='1.0' encoding='utf-8'?>
<document id="29277663"><sentence text="OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam."><entity charOffset="61-73" id="DDI-PubMed.29277663.s1.e0" text="piperacillin" /><entity charOffset="78-88" id="DDI-PubMed.29277663.s1.e1" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s1.e0" e2="DDI-PubMed.29277663.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s1.e0" e2="DDI-PubMed.29277663.s1.e1" /></sentence><sentence text="This study aimed to demonstrate that organic anion transporters (OATs) mediate the drug-drug interaction (DDI) between piperacillin and tazobactam"><entity charOffset="119-131" id="DDI-PubMed.29277663.s2.e0" text="piperacillin" /><entity charOffset="136-146" id="DDI-PubMed.29277663.s2.e1" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s2.e0" e2="DDI-PubMed.29277663.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s2.e0" e2="DDI-PubMed.29277663.s2.e1" /></sentence><sentence text=" After co-administration with piperacillin in rats, the AUC of tazobactam in plasma was significantly increased, and t1/2β was prolonged with significant reduction in plasma clearance, renal clearance and cumulative urinary excretion"><entity charOffset="30-42" id="DDI-PubMed.29277663.s3.e0" text="piperacillin" /><entity charOffset="63-73" id="DDI-PubMed.29277663.s3.e1" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s3.e0" e2="DDI-PubMed.29277663.s3.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s3.e0" e2="DDI-PubMed.29277663.s3.e1" /></sentence><sentence text=" In rat and human kidney slices, probenecid, p-aminohippurate and benzylpenicillin inhibited the uptake of piperacillin and tazobactam"><entity charOffset="33-43" id="DDI-PubMed.29277663.s4.e0" text="probenecid" /><entity charOffset="45-61" id="DDI-PubMed.29277663.s4.e1" text="p-aminohippurate" /><entity charOffset="66-82" id="DDI-PubMed.29277663.s4.e2" text="benzylpenicillin" /><entity charOffset="107-119" id="DDI-PubMed.29277663.s4.e3" text="piperacillin" /><entity charOffset="124-134" id="DDI-PubMed.29277663.s4.e4" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e0" e2="DDI-PubMed.29277663.s4.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e0" e2="DDI-PubMed.29277663.s4.e1" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e0" e2="DDI-PubMed.29277663.s4.e2" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e0" e2="DDI-PubMed.29277663.s4.e3" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e0" e2="DDI-PubMed.29277663.s4.e4" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e1" e2="DDI-PubMed.29277663.s4.e1" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e1" e2="DDI-PubMed.29277663.s4.e2" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e1" e2="DDI-PubMed.29277663.s4.e3" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e1" e2="DDI-PubMed.29277663.s4.e4" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e2" e2="DDI-PubMed.29277663.s4.e2" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e2" e2="DDI-PubMed.29277663.s4.e3" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e2" e2="DDI-PubMed.29277663.s4.e4" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e3" e2="DDI-PubMed.29277663.s4.e3" /><pair ddi="false" e1="DDI-PubMed.29277663.s4.e3" e2="DDI-PubMed.29277663.s4.e4" /></sentence><sentence text=" Piperacillin significantly inhibited the uptake of tazobactam"><entity charOffset="1-13" id="DDI-PubMed.29277663.s5.e0" text="Piperacillin" /><entity charOffset="52-62" id="DDI-PubMed.29277663.s5.e1" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s5.e0" e2="DDI-PubMed.29277663.s5.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s5.e0" e2="DDI-PubMed.29277663.s5.e1" /></sentence><sentence text=" Moreover, the uptakes of piperacillin, tazobactam and sulbactam in hOAT1/3-HEK293 cells were significantly higher compared with mock-HEK293 cells, respectively"><entity charOffset="26-38" id="DDI-PubMed.29277663.s6.e0" text="piperacillin" /><entity charOffset="40-50" id="DDI-PubMed.29277663.s6.e1" text="tazobactam" /><entity charOffset="55-64" id="DDI-PubMed.29277663.s6.e2" text="sulbactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s6.e0" e2="DDI-PubMed.29277663.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s6.e0" e2="DDI-PubMed.29277663.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29277663.s6.e0" e2="DDI-PubMed.29277663.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29277663.s6.e1" e2="DDI-PubMed.29277663.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29277663.s6.e1" e2="DDI-PubMed.29277663.s6.e2" /></sentence><sentence text=" Piperacillin significantly inhibited the uptake of tazobactam in hOAT1/3-HEK293 cells"><entity charOffset="1-13" id="DDI-PubMed.29277663.s7.e0" text="Piperacillin" /><entity charOffset="52-62" id="DDI-PubMed.29277663.s7.e1" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s7.e0" e2="DDI-PubMed.29277663.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s7.e0" e2="DDI-PubMed.29277663.s7.e1" /></sentence><sentence text=" The Km values of tazobactam (431 ± 67 μM for hOAT1, 377 ± 63 μM for hOAT3) were significantly higher than those of piperacillin (37 ± 5 μM for hOAT1, 172 ± 28 μM for hOAT3)"><entity charOffset="18-28" id="DDI-PubMed.29277663.s8.e0" text="tazobactam" /><entity charOffset="116-128" id="DDI-PubMed.29277663.s8.e1" text="piperacillin" /><pair ddi="false" e1="DDI-PubMed.29277663.s8.e0" e2="DDI-PubMed.29277663.s8.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s8.e0" e2="DDI-PubMed.29277663.s8.e1" /></sentence><sentence text=" This suggested that piperacillin has a stronger affinity to hOAT1/3 than tazobactam"><entity charOffset="21-33" id="DDI-PubMed.29277663.s9.e0" text="piperacillin" /><entity charOffset="74-84" id="DDI-PubMed.29277663.s9.e1" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s9.e0" e2="DDI-PubMed.29277663.s9.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s9.e0" e2="DDI-PubMed.29277663.s9.e1" /></sentence><sentence text=" Meanwhile, the Km values of tazobactam were increased in the presence of piperacillin with unchanged Vmax"><entity charOffset="29-39" id="DDI-PubMed.29277663.s10.e0" text="tazobactam" /><entity charOffset="74-86" id="DDI-PubMed.29277663.s10.e1" text="piperacillin" /><pair ddi="false" e1="DDI-PubMed.29277663.s10.e0" e2="DDI-PubMed.29277663.s10.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s10.e0" e2="DDI-PubMed.29277663.s10.e1" /></sentence><sentence text=" This indicated that piperacillin inhibited the uptake of tazobactam in a competitive manner"><entity charOffset="21-33" id="DDI-PubMed.29277663.s11.e0" text="piperacillin" /><entity charOffset="58-68" id="DDI-PubMed.29277663.s11.e1" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s11.e0" e2="DDI-PubMed.29277663.s11.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s11.e0" e2="DDI-PubMed.29277663.s11.e1" /></sentence><sentence text=" In conclusion, piperacillin and tazobactam are the substrates of hOAT1/3, and OAT1/3 mediate the DDI between piperacillin and tazobactam"><entity charOffset="16-28" id="DDI-PubMed.29277663.s12.e0" text="piperacillin" /><entity charOffset="33-43" id="DDI-PubMed.29277663.s12.e1" text="tazobactam" /><entity charOffset="110-122" id="DDI-PubMed.29277663.s12.e2" text="piperacillin" /><entity charOffset="127-137" id="DDI-PubMed.29277663.s12.e3" text="tazobactam" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e0" e2="DDI-PubMed.29277663.s12.e0" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e0" e2="DDI-PubMed.29277663.s12.e1" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e0" e2="DDI-PubMed.29277663.s12.e2" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e0" e2="DDI-PubMed.29277663.s12.e3" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e1" e2="DDI-PubMed.29277663.s12.e1" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e1" e2="DDI-PubMed.29277663.s12.e2" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e1" e2="DDI-PubMed.29277663.s12.e3" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e2" e2="DDI-PubMed.29277663.s12.e2" /><pair ddi="false" e1="DDI-PubMed.29277663.s12.e2" e2="DDI-PubMed.29277663.s12.e3" /></sentence><sentence text="" /></document>